# |
Searches |
Results |
1 |
small cell lung cancer.mp. |
66,316 |
2 |
exp Small Cell Lung Carcinoma/ |
3993 |
3 |
1 or 2 |
67,529 |
4 |
immunotherapy.mp. |
105,565 |
5 |
Programmed Cell Death 1 Receptor/or PD1 inhibitor.mp. or PDL1 inhibitor.mp. |
6485 |
6 |
CTLA-4 Inhibitor.mp. |
91 |
7 |
pembrolizumab.mp. |
3958 |
8 |
nivolumab.mp. or nivolumab/ |
5008 |
9 |
ipilimumab.mp. or Ipilimumab/ |
3565 |
10 |
avelumab.mp. |
422 |
11 |
tremelimumab.mp. |
283 |
12 |
atezolizumab.mp. |
1067 |
13 |
durvalumab.mp. |
503 |
14 |
4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 |
114,500 |
15 |
Antineoplastic Agents/ |
277,204 |
16 |
cisplatin.mp. or Cisplatin/ |
75,659 |
17 |
carboplatin.mp. or Carboplatin/ |
17,588 |
18 |
Paclitaxel.mp. or Paclitaxel/ |
37,346 |
19 |
etoposide.mp. or Etoposide/ |
25,396 |
20 |
chemotherapy.mp. |
441,677 |
21 |
15 or 16 or 17 or 18 or 19 or 20 |
669,235 |
22 |
randomised controlled trial.pt. |
507,927 |
23 |
controlled clinical trial.pt. |
93,720 |
24 |
randomised.ab. |
483,103 |
25 |
placebo.ab. |
208,619 |
26 |
drug therapy.fs. |
2,212,406 |
27 |
randomly.ab. |
335,363 |
28 |
trial.ab. |
509,238 |
29 |
groups.ab. |
2,058,166 |
30 |
22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 |
472,7391 |
31 |
animals/ |
6,621,020 |
32 |
human/ |
18,535,892 |
33 |
31 not (31 and 32) |
4,675,617 |
34 |
30 not 33 |
4,101,212 |
35 |
3 and 14 and 21 and 34 |
1125 |
35 |
limit 34 to yr = “2010-Current” |
1040 |